Jimpy is a shortened life-span murine mutant whose genetic disorder results in severe pathological alterations in the CNS, including Ž . hypomyelination, oligodendrocyte death and strong astroglial and microglial reaction. The knowledge of metallothionein MT regulation in the CNS and especially of MT presence in specific glial cell types under pathological conditions is scarce. In the present study, immunocytochemical detection of MT-I q II has been performed in spinal cord sections from 10-12-and 20-22-day-old jimpy and normal animals. The identification of MT-positive glial cells was achieved through double labeling combining MT immunocytochemistry and selective markers for oligodendrocytes, astrocytes and microglia. MT was found in glial cells and was present in the spinal cord of jimpy and normal mice at both ages, but there were remarkable differences in MT expression and in the nature of MT-positive glial cells depending on the type of mouse. The number of MT-positive cells was higher in jimpy than in normal spinal cords. This was apparent in all spinal cord areas, although it was more pronounced in white than in the gray matter and at 20-22 days than at 10-12 days. The mean Ž . Ž . number of MT-positive glia in the jimpy white matter was 1.9-fold 10-12 days and 2.4-fold 20-22 days higher than in the normal one. Astrocytes were the only parenchymal glial cells that were positively identified as MT-producing cells in normal animals. Interestingly, MT in the jimpy spinal cord was localized not only in astrocytes but also in microglial cells. The occurrence of MT induction in relation to reactive astrocytes and microglia, and its role in neuropathological conditions is discussed. q 1997 Elsevier Science B.V.
Introduction
Jimpy is an X-linked recessive disorder in which central Ž . nervous system CNS pathology in affected male mice results in a 95% reduction in the amount of CNS myelin w x 65 . Jimpy animals begin to exhibit body tremors at 8-10 days of age and die before day 30. The genetic defect consists in a point mutation in the gene coding for a major Ž . CNS myelin component, the proteolipid protein PLP w x 17 . Besides the myelin deficit, histological studies revealed severe alterations in relation to glial cells. Alterations in oligodendroglial cells include protracted proliferw x w x ation 57 , cell cycle irregularities 30,64 and a drastic reduction in the number of well-differentiated oligodendrow x cytes as a consequence of their premature death 33 . Astrocytes in jimpy exhibit a pronounced gliosis with the ) Ž . Corresponding author. Fax: q34 3 581-2392. w x occurrence of numerous hypertrophied astrocytes 6,56 Ž . showing an increased glial fibrillary acidic protein GFAP w x content and mRNA expression 38 . In addition, jimpy astrocytes are unable to increase oxygen uptake in req w x sponse to K -induced stimulation 27 , show an increased w x w x intracellular Ph 32 and their cell cycle is lengthened 31 . In regard to the microglial cell population, an intense microglial reaction has been described in the jimpy spinal w x cord 61 . In contrast to the typical ramified appearance and regularly-spaced distribution of 'resting' microglia w x observed in different normal CNS areas 10,34,62 , the jimpy microglia show reactive morphological features and w x their number is largely increased 61 . In the spinal cord, the mean microglial densities in the mutant white matter Ž . Ž are about threefold 10-12 days and fivefold [20] [21] [22] . days higher than in normal animals. These increased numbers of microglia are in accordance with the reactive w x proliferation of these cells 64 . A specific physical relation ( )between microglial cells and apoptotic oligodendrocytes w x has also been described in the jimpy spinal cord 63 . These reactive glial alterations strongly suggest a disturbance in the development and relations of glial cells resulting from an intrinsic CNS damage.
Ž . Metallothioneins MTs constitute a class of metal-binding proteins whose expression is known to markedly increase following injury and inflammation in several tissues w x 24,50 . In fact, MT is now considered to play a significant role in cellular defense mechanisms and is thought to play a protective role against oxidative damage in tissue injury w x and inflammation 50 . Cytokines which are mediators of various kinds of inflammatory and immune responses, Ž . Ž . such as interleukin-1 IL-1 and -6 IL-6 , tumor necrosis Ž . Ž . factor-a TNF-a and interferon-g IFN-g , are effective w x inducers of hepatic MT 18,51 . Interestingly, glucocorticoids, LPS and the cytokines IL-1 and IL-6 induce astrow x cytic MT in vitro 14,18,28,51,52 . In vivo, MT expression w x in astrocytes is also increased in injured CNS 46,55 , but only limited attention has been paid to its distribution, regulation and function in CNS pathology. In addition, there are no available studies focused on the unambiguous identification of MT-positive cells and it remains to be determined if glial cells other than astrocytes might express MT under pathological conditions.
The aim of the present study was to analyze the production of MT and to determine the nature of MT-positive cells in spinal cords from the hypomyelinated jimpy mouse. MT expression in spinal cord sections from jimpy and normal male littermates of 10-12 and 20-22 days old was assessed by immunocytochemistry using a monoclonal antibody specific for the MT-I and MT-II isoforms. The identification of MT-positive cells was achieved through double labeling combining MT immunocytochemistry with selective markers for oligodendrocytes, astrocytes and microglia.
Materials and methods

Experimental animals
C57BLr6J mice used in this study were males raised here in the UAB animal center by mating jimpy carrier Ž . females jprq obtained from the Institute Pasteur with Ž . Ž . normal males qrY . Jimpy hemizygous males jprY Ž . were distinguished from normal control males qrY by their characteristic motor tremors and drastic myelin reduction. Five jimpy mice of 10-12 and five of 20-22 days old were used in this study. The same number of normal male littermates of each age were used as controls.
Preparation of sections
Animals were anesthetized with sodium pentobarbital Ž . 100 mgrkg body weight and sacrificed by intracardiac perfusion with a 4% paraformaldehyde solution in 0.1 M phosphate buffer, pH 7.2, for 5 min. The cervical segment of the spinal cord was removed and placed in the same fixative for 4 h at 48C. Samples were then rinsed in phosphate buffer for 4 h, dehydrated in graded ethanol, cleared in xylene and embedded in paraffin. Spinal cords were coronally sliced with a microtome to obtain 10-mm thick sections that were mounted on glass slides pretreated Ž . with 1:10 poly-L-lysine solution Sigma . Finally, sections were dewaxed, hydrated and immunocytochemically processed.
Immunocytochemical reaction for MT
Sections were treated for 10 min with 2% H O in 2 2 100% methanol to block endogenous peroxidase, rinsed Ž . 3=5 min in 0.05 M Trizma base saline TBS and Ž . sequentially incubated for: 1 30 min at room temperature Ž . RT in TBS containing 10% fetal calf serum and 0.1% Ž . Ž . Ž . bovine serum albumin BSA blocking buffer; BB ; 2 overnight at 48C with the primary monoclonal mouse Ž . anti-MT antibody E9 generous gift from Dr. Pete Kille Ž . . containing 50 mg 3,3 -diaminobenzidine DAB; Sigma , 4 ml of 1% ammonium nickel sulfate, 5 ml of 1% cobalt chloride and 66 ml H O . Finally, sections were rinsed, 2 2 dehydrated in graded ethanol, cleared in xylene, and coverslipped in DPX. As a control for the immunocytochemical staining, the primary antibody was omitted.
Double-labeling technique
Simultaneous demonstration of MT and astroglia, oligodendroglia or microglia was achieved through the sequential combination of MT immunostaining and selective markers for these glial cells. Astrocytes were demonstrated by immunocytochemical detection of glial fibrillary acidic Ž . w x protein GFAP 7 and oligodendroglial cells by immun-Ž . w x odetection of myelin basic protein MBP 58 . The microglial cell population was demonstrated by tomato lectin w x histochemistry, a marker for both normal 2 and reactive w x microglia 1,63 .
In brief, sections were rinsed 3 = 5 min in TBS, treated for 10 min with 2% H O in 100% methanol to block 2 2 peroxidase and rinsed again 3 = 5 min in TBS including 0.1% Triton X-100. Sections were placed in BB for 30 min to reduce unspecific staining, and incubated overnight at Ž . ) 15 mgrml in TBS. After rinsing 3 = 5 min in TBS with 0.1% Triton X-100, the sections reacted with primary anti-GFAP and anti-MBP antibodies were incubated for 60 min at RT with a secondary anti-rabbit IgG biotinylated Ž . antibody Amersham in a 1:200 dilution in BB. Finally, all sections were rinsed 3 = 5 min in TBS with 0.1% Triton X-100 and incubated for 60 min at RT with Ž . avidin-peroxidase Sigma in a 1:600 dilution in BB. The peroxidase reaction was visualized using DAB as chromogen but without metal intensification. As a control for the double staining, either the primary antibodies or the lectin were omitted. In order to estimate the percentage of MT-positive cells simultaneously expressing either the oligodendrocytic, the astrocytic or the microglial marker, two sections per animal, from a total of 10 jimpy and 10 normal spinal cord sections per age, processed for the three different doublelabeling techniques, were analyzed under the microscope by using a 40 = objective, or even a 100 = objective when necessary.
Quantification and identification of MT-positiÕe cells
Cross-reactiÕity of the monoclonal antibody E9 for MT isoforms
In brain studies it is essential to distinguish between the classic MT isoforms, MT-I and MT-II, and the more recently discovered brain-specific MT isoform, MT-III.
The monoclonal antibody E9 has been extensively used by several investigators and is now commercially available Ž . from Dakopatts M 0639 , but the specificity of this antibody regarding its cross-reaction with MT-III is unknown. In this study, we have developed an enzyme-linked im-Ž . munosorbent assay ELISA in order to characterize the cross-reactivity of the monoclonal mouse anti-MT antibody E9 with the different MT isoforms.
Polystyrene plates were coated overnight with increas-Ž . ing amounts up to 100 ngrwell of purified rat liver MT-I w x Ž and MT-II 22 or recombinant rat MT-III plasmid gener-. ously provided by Dr. Pete Kille in 100 mM carbonate buffer, pH 9.6, at room temperature and in a water-saturated atmosphere. Plates were rinsed three times for 5 min with Ž . 0.05% Tween-20 in phosphate-buffered saline T-PBS , and the remaining active groups were blocked by incubation for 2 h with 200 mlrwell of T-PBS containing 1% BSA. The plates were rinsed as above and incubated for 2 h at 378C in a water-saturated atmosphere with 100 mlrwell of a 1:10 000 dilution in T-PBSq BSA of the E9 antibody. After rinsing, the plates were incubated for 2 h with 200 mlrwell of anti-mouse IgG biotinylated antibody mM phosphate buffer, pH 7, was added, and finally the absorbance was read at 600 nm.
Results
Distribution and number of MT-positiÕe cells
Microscopical examination of spinal cord sections immunocytochemically processed for MT using the E9 monoclonal antibody revealed that MT-positive cells were present in the gray and white matter of both the 10-12-Ž . and the 20-22-day-old normal and jimpy animals When comparing jimpy and normal animals, the mean number of MT-positive cells in the spinal cord was significantly higher in the mutants, this difference being more pronounced in white than in the gray matter and at 20-22 days than at 10-12 days. In white matter, the number of MT-positive cells at 10-12 days was about 1.9-fold higher in jimpy than in normal animals, whereas it was 2.4-fold higher at 20-22 days. In gray matter, the number of MT-positive cells at 10-12 days was 2-fold higher in jimpy than in normal cords, but the difference was not statistically significant at 20-22 days. Differences not only in the numbers of MT-positive cells but also in the intensity of MT immunostaining were found when jimpy and control animals were compared. Although quantitative image analysis has not been performed, an increased intensity of immunostaining in jimpy MT-positive glial cells was Ž . clearly noticed in the white matter Fig. 1 .
In addition to parenchymal glial cells, MT immunoreactivity was found in ependymal cells of the central canal, meningeal cells of the pia mater and, occasionally, in vascular endothelial cells and neurons. Positive MT immunostaining of the ependyma was located in the nucleus and cytoplasm, and was very often concentrated at the apical cytoplasmic portion. Both nuclear and cytoplasmic immunostaining was found in pial cells. Immunostaining of endothelial cells was predominantly located in the cytoplasm. Neurons showing a weak cytoplasmic MT immunostaining were rarely recognized. We were not able to establish differences in the number and distribution of MT-positive blood vessels, neurons, pial cells and ependymal cells when comparing sections from jimpy and normal animals.
Identification of MT-positiÕe cells
In parenchymal glial cells, the MT immunostaining was predominantly found in the nucleus, whereas the cytoplasm and processes were frequently devoid of staining or stained weakly andror incompletely. Thus, the unambiguous and exhaustive identification of MT-positive cells on the basis of their morphological features is unfeasible in sections exclusively reacted for MT. The double staining procedure combining MT immunostaining with specific glial cell markers enabled us to simultaneously visualize Ž . MT-positive cells black staining and the different glial Ž . cell types brownish staining . The percentages of MTpositive cells expressing the different glial cell markers are shown in Table 1 , and photomicrographs showing doublelabeled glial cells are presented in Fig. 3 .
In normal mice, at both ages, there was a consistent correspondence between the location of MT immunoreactivity and the localization of GFAP-positive astrocytes in white matter. Most GFAP-positive astrocytes showed MT immunostaining and nearly 100% of MT-positive cells were GFAP-positive in the white matter. The exhaustive identification of MT-positive cells through double MTrGFAP immunostaining was not possible in gray matter, since GFAP immunoreactivity was mainly located in white matter and most astrocytes in the gray matter of the normal spinal cord showed weak or no detectable GFAP immunostaining. Microglial cells present in the gray and white matter were negative for MT in the normal spinal cord at both ages. The identification of MT-positive cells after double MTrMBP immunostaining could not be accomplished in the normal spinal cord due to the strong MBP immunoreactivity of the densely packed myelinated fibers.
In jimpy, most glial cells showing MT immunoreactivity were astrocytes, although a significant number of MT-Ž . positive cells were microglial cells Table 1 . In the white matter, the percentage of MT-positive cells that were Ž . GFAP-positive ranged from 86% 10-12 days to 82% Ž . 20-22 days . GFAP-positive astrocytes lacking MT-immunoreactivity in the mutant white matter were very scarce. In the gray matter, at both ages, about 70% of MT-positive 
Specificity of the monoclonal antibody E9 for MT isoforms
The cross-reactivity of the E9 monoclonal antibody with the different brain MT isoforms was assessed by ELISA. The results indicated that the antibody E9 reacts with MT-I and MT-II, but no cross-reactivity was observed with MT-III.
Discussion
In the present study, immunocytochemical detection of MT was assessed by using a monoclonal antibody specific for the MT-I and MT-II isoforms. In rodents, the multiple MT isoforms have been subdivided into four structurally Ž . distinct subgroups MT-I, MT-II, MT-III and MT-IV . The MT-I and MT-II proteins are widely distributed in mammalian tissues, including brain, and their expression is w x inducible by metals and glucocorticoids 24 ; MT-III, also Ž . called growth inhibitory factor GIF , is expressed mostly in the brain and does not appear to be regulated by metals w x or glucocorticoids 45,60 ; and MT-IV is exclusively exw x pressed in stratified squamous epithelia 48 . In this article, Ž . we use the term 'metallothionein MT ' to refer to the classic MT-I and MT-II isoforms.
MT was present both in the spinal cord of 10-12-and 20-22-day-old jimpy and normal mice, but there were remarkable differences in the numbers of MT-positive glial Ž . cells depending on the type of mouse normal or jimpy , Ž . the age of the animal 10-12 or 20-22 days , and the Ž . location gray or white matter . Differences not only in numbers but also in the nature of MT-positive glial cells were found when jimpy and normal animals were compared.
Distribution of MT in normal animals
In the normal spinal cord, the number of MT-positive cells was higher at 20-22 days than at 10-12 days, this difference being mainly due to an increase with age in the number of MT immunopositive cells present in the gray matter. This is in agreement with previous observations reporting that MT is expressed only in minute amounts in the embryonic and neonatal rodent brain and that its expression progressively increases during the first weeks w x of the postnatal development 43, 59 . In addition to age-related differences, MT is not uniformly distributed through the normal CNS and regional differences in the MT prow x tein and MT mRNA content 14,20,21,25,28 , as well as in w x the distribution of MT-positive cells 8,28 , have been described. The regional differences are difficult to analyze since the distribution of MT depends on the area and even, within each area, on the specific layer examined. Nevertheless, MT immunoreactivity is preferentially located in gray matter areas and the number of MT-positive cells is usuw x ally higher in gray than in white matter 8 . Our quantitative study in the mouse spinal cord is in accordance with these observations.
Astrocytes showing double MTrGFAP immunostaining were regularly seen through the normal spinal cord and there was a consistent correspondence between the location of MT and GFAP, particularly in white matter. In gray matter, most GFAP-positive astrocytes showed MT immunoreactivity, but it must be noted that a considerable percentage of MT-positive glial cells were devoid of apparent GFAP immunostaining. This may be explained by the fact that GFAP immunoreactivity is mainly located in white matter astrocytes and astrocytes in the gray matter of the normal spinal cord often show insufficient GFAP immunoreactivity to be unequivocally detected by imw x munohistochemical techniques 19 . Parenchymal glial cells showing MT immunoreactivity showed negative staining for the tomato lectin microglial marker. The identification of MT-positive glial cells after double MTrMBP immunostaining could not be accomplished due to the strong MBP immunoreactivity of myelinated fibers. Thus, rigorously, we cannot exclude the possibility that some MT-positive glial cells were oligodendrocytes, but our observations in the normal mouse spinal cord, taken together with the observations of other authors in different normal brain w x areas and species 42,43,66 , strongly suggest that astrocytes are the only parenchymal glial cell that constitutively express MT in normal adult CNS.
MT-containing neurons were very rare in the spinal cord. In accordance with the present study, most studies on MT expression in CNS describe the absence or scarcity of w x MT-immunopositive neurons 8, 42, 43, 66 . On the other w x hand, by using polyclonal antibodies, Hidalgo et al. 28 found MT immunoreactivity in neurons of different rat cerebral and cerebellar areas. MT-I levels, measured by radioimmunoassay, were, however, 10-times lower in cul-( )tured neurons than in cultured astrocytes. The expression of low MT levels by neurons is also supported by the w x observations of Kiningham et al. 29 , who reported MT immunoreactivity in some motoneurons of both rat and human spinal cords by using the same monoclonal antibody used by us in this study, but including a trypsin treatment previous to the application of antibodies.
Induction of MT in jimpy
The number of glial cells showing MT immunostaining was higher in the jimpy spinal cord than in normal cords, and MT-positive glial cells in jimpy stained more intensely than positive cells in normal animals. This suggests that there is an induction of MT expression in jimpy and that MT induction implies not only an increase in the number of glial cells synthesizing MT but also an increase in the production of MT by glial cells. Interestingly, MT in the jimpy spinal cord was localized not only in astrocytes but also in microglial cells. The production of MT by microglia is a differential feature in jimpy, but the amount of microglial cells showing MT immunoreactivity is insufficient to explain the increase in number of MT-positive glial cells observed in the mutant. Thus, the de novo MT synthesis is apparently induced in both microglia and astrocytes. Moreover, MT induction was more pronounced in white than in gray matter, and it is known that the w x w x degree of microglial 61 and astroglial reactivity 6,56 is also higher in the jimpy white than in the gray matter, thus suggesting a close correspondence between the degree of MT induction and the degree of glial reactivity.
Microglia belong to the monocytermacrophage system w x and are the specialized macrophages in the CNS 47 . There is no previous observation in the literature describing MT in microglia, but some studies have described MT induction in monocytes and macrophages in other tissues. Human monocytes are induced to express MT after exposure to zinc, cadmium and the glucocorticoid dexamethaw x sone 40 . In the same way, treatment with cadmium w x induces MT expression in alveolar macrophages 26 , w x w x Kupffer cells 39 and mesangial cells 13 . Thus, the ability to express MT when conveniently stimulated seems to be an intrinsic feature of monocytesrmacrophages. Ž . Interestingly, bacterial lipopolysaccharide LPS induces MT expression in both primary human monocytes and a monocyte-derived cell line, and this MT induction is concurrent with increased production of H O and enhanced 2 2 adherence and invasiveness, suggesting that MT expression is associated with the reactive activation of these cells w x 36,37 .
The induction of MT in reactive astrocytes has been w x previously described in brain injury 46 and in neurodegenerative disorders such as amyotrophic lateral sclerosis w x 55 . Factors known to increase MT production by astrow x cytes include metals 28,49,52 and, interestingly, factors involved in the regulation of inflammatory and immunological responses, such as glucocorticoids, LPS and the w x cytokines IL-1 and IL-6 14,18,28,51,52 . Following experimental invasive injury, induction of MT is accompanied by massive extravasation of plasma metals in the damaged w x area 46 . Metals arising from the blood may potentially induce MT expression in astrocytes and microglia in the case of CNS invasive lesions, but this is unlikely in jimpy mice since its tissue damage results from an intrinsic genetic lesion, without the occurrence of traumatic injuries. On the contrary, molecules generated locally in the jimpy parenchyma seem to be the most likely signals for this local induction of MT in certain, but not all, astrocytes and microglial cells. Among known MT inducers, cytokines seem to be the best candidates for the induction of MT in injured CNS. In fact, the induction of MT synthesis by some interleukins has been demonstrated in the brain w x 18,51 , and it is known that glial cells possess receptors w x for these cytokines 44 and that, under pathological conditions, these cytokines are released into the CNS w x w x parenchyma 5 . The intense reaction of astrocytes 56 and w x microglia 61 observed in jimpy may have special relevance since these cells, when they become reactive, are the w x main source of cytokines in the damaged brain 5,23 . Accordingly, the occurrence of anomalous glial-glial interactions involving the secretion of defective or abnormal w x soluble factors has been proposed in jimpy 3 .
Functional significance of MT
It is generally accepted that the principal role of MT in normal tissues lies in the homeostasis of essential trace w x metals 24 . MT has the capability to bind group II metal ions, particularly zinc and copper. These metals are essential for normal brain functions, but it is important to keep the levels of free metals within physiological limits. MT is a good candidate to chelate excess metals and release them when needed. The presence of MT in endothelial cells, ependymal cells, pial cells and especially in astrocytes, a widely distributed and regularly-spaced cell population which is in contact with the meningeal covering and blood vessels, give support to this hypothesis. There is, however, an accumulating body of evidence which indicate that MT plays a protective role against oxidative damage in pathow x logical conditions 50 . In fact, the role of MT as antioxidant could not be completely separated from its role in the storagerdetoxification of metals, since some metal ions are capable of generating reactive oxygen species by the w x redox Fenton reaction 50 . Chemicals that produce oxidaw x tive stress are effective MT inducers 4 and it is known that MT confers resistance to cells from the cytotoxic effects of oxidants by acting as a free radical scavenger w x 50,53,54 . Accordingly, embryonic cells from transgenic mice deficient in MT-I and -II genes were more sensitive to the cytotoxic effects of oxidants than normal embryonic w x cells 35 . The subcellular location of MT may be important for its antioxidant function. Most of the MT was ( )concentrated in the nucleus and there is evidence for DNA w x damage by reactive oxygen species 50 . MT may protect DNA by sequestering metals and preventing their participation in redox reactions generating reactive oxygen species w x 9 or by directly interacting with oxygen free radicals and w x precluding the strand scission of DNA 15 . Cytoplasmic MT also protects cells from reactive oxygen species and w x other oxidants that induce cytotoxic peroxidation 54 . A role for MT in reducing nitric oxide-induced cytoplasmic w x and nuclear toxicity has also been described 53 .
Reactive microglia generate reactive oxygen species, i.e. superoxide anion, hydrogen peroxide and hydroxyl w x w x radical 16 , and nitric oxide 12 , the production of these w x free radicals being regulated by cytokines 11 . There is no direct evidence for the production of free radicals by jimpy reactive microglial cells. Nevertheless, jimpy microglia actively remove oligodendrocyte and myelin debris through w x phagocytosis 61,63 and it is known that phagocytes, and microglia in particular, increase the consumption of oxygen and release reactive oxygen species and nitric oxide w x during phagocytosis 16,41 . The microglial production of free radicals mediating oxidative damage is essential, in our opinion, for understanding the role of MT induction in injured CNS. Further studies on MT are needed for the accurate identification of glial-inducing factors and a better understanding of its function during pathological conditions.
